Stock chart
Ticker: KALA Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-07 2025-01-06 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
1,706 -2.4%
7.63
USD 13,017
1,706 -2.4% 7.63 USD 13,017
2025-01-07 2025-01-06 PS Planned sale

Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
2,021 -2.9%
7.63
USD 15,420
2,021 -2.9% 7.63 USD 15,420
2025-01-07 2025-01-06 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
2,446 -2.6%
7.63
USD 18,663
2,446 -2.6% 7.63 USD 18,663
2025-01-07 2025-01-06 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
5,779 -2.0%
7.63
USD 44,094
5,779 -2.0% 7.63 USD 44,094
2024-12-31 2024-12-30 B Purchase

BAKER BROS. ADVISORS LP

Large shareholder
279,939 +34.8%
6.44
USD 1,802,807
279,939 +34.8% 6.44 USD 1,802,807
2024-12-31 2024-12-30 B Purchase

BAKER BROS. ADVISORS LP

Large shareholder
30,620 +34.8%
6.44
USD 197,193
30,620 +34.8% 6.44 USD 197,193
2024-06-27 2024-06-26 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
15,168 -5.4%
4.75
USD 72,048
15,168 -5.4% 4.75 USD 72,048
2024-06-27 2024-06-26 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
4,163 -6.5%
4.75
USD 19,774
4,163 -6.5% 4.75 USD 19,774
2024-06-27 2024-06-26 PS Planned sale

Bazemore Todd

SEE REMARKS

Officer
4,653 -5.3%
4.75
USD 22,102
4,653 -5.3% 4.75 USD 22,102
2024-06-27 2024-06-26 PS Planned sale

Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
5,158 -7.9%
4.75
USD 24,501
5,158 -7.9% 4.75 USD 24,501
2024-06-27 2024-06-26 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
5,489 -6.1%
4.75
USD 26,073
5,489 -6.1% 4.75 USD 26,073
2024-06-03 2024-05-31 PS Planned sale

Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
231 -0.4%
6.09
USD 1,407
231 -0.4% 6.09 USD 1,407
2024-06-03 2024-05-31 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
7,392 -2.6%
6.09
USD 45,017
7,392 -2.6% 6.09 USD 45,017
2024-06-03 2024-05-31 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
2,002 -2.2%
6.09
USD 12,192
2,002 -2.2% 6.09 USD 12,192
2024-06-03 2024-05-31 PS Planned sale

Bazemore Todd

SEE REMARKS

Officer
2,093 -2.3%
6.09
USD 12,746
2,093 -2.3% 6.09 USD 12,746
2024-06-03 2024-05-31 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
1,786 -2.7%
6.09
USD 10,877
1,786 -2.7% 6.09 USD 10,877
2024-01-05 2024-01-04 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
1,617 -1.7%
6.74
USD 10,899
1,617 -1.7% 6.74 USD 10,899
2024-01-05 2024-01-04 PS Planned sale

Trachtenberg Eric

SEE REMARKS

Officer
1,227 -1.8%
6.74
USD 8,270
1,227 -1.8% 6.74 USD 8,270
2024-01-05 2024-01-04 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
1,227 -1.8%
6.74
USD 8,270
1,227 -1.8% 6.74 USD 8,270
2024-01-05 2024-01-04 PS Planned sale

Kharabi Darius

CHIEF BUSINESS OFFICER

Officer
1,385 -2.1%
6.73
USD 9,321
1,385 -2.1% 6.73 USD 9,321
2024-01-05 2024-01-04 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
4,539 -1.6%
6.73
USD 30,547
4,539 -1.6% 6.73 USD 30,547
2023-01-06 2023-01-04 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
73 -0.4%
28.53
USD 2,083
73 -0.4% 28.53 USD 2,083
2023-01-06 2023-01-04 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
60 -0.5%
28.54
USD 1,712
60 -0.5% 28.54 USD 1,712
2023-01-06 2023-01-04 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
198 -0.4%
28.54
USD 5,651
198 -0.4% 28.54 USD 5,651
2023-01-06 2023-01-04 PS Planned sale

Bazemore Todd

SEE REMARKS

Officer
62 -0.4%
28.54
USD 1,769
62 -0.4% 28.54 USD 1,769
2023-01-06 2023-01-04 PS Planned sale

Trachtenberg Eric

SEE REMARKS

Officer
60 -0.5%
28.55
USD 1,713
60 -0.5% 28.55 USD 1,713
2022-10-28 2022-10-26 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
561 -11.2%
6.52
USD 3,658
561 -11.2% 6.52 USD 3,658
2022-10-28 2022-10-26 PS Planned sale

Bazemore Todd

SEE REMARKS

Officer
214 -9.3%
6.51
USD 1,393
214 -9.3% 6.51 USD 1,393
2022-10-28 2022-10-26 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
261 -4.3%
6.51
USD 1,699
261 -4.3% 6.51 USD 1,699
2022-10-28 2022-10-26 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
194 -7.4%
6.51
USD 1,263
194 -7.4% 6.51 USD 1,263
2022-10-28 2022-10-26 PS Planned sale

Trachtenberg Eric

SEE REMARKS

Officer
194 -8.7%
6.52
USD 1,265
194 -8.7% 6.52 USD 1,265
2022-06-29 2022-06-27 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
7,975 -3.1%
0.37
USD 2,951
7,975 -3.1% 0.37 USD 2,951
2022-06-29 2022-06-27 PS Planned sale

Bazemore Todd

SEE REMARKS

Officer
3,092 -2.6%
0.37
USD 1,144
3,092 -2.6% 0.37 USD 1,144
2022-06-29 2022-06-27 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
3,144 -1.1%
0.37
USD 1,163
3,144 -1.1% 0.37 USD 1,163
2022-06-29 2022-06-27 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
2,613 -2.0%
0.37
USD 967
2,613 -2.0% 0.37 USD 967
2022-06-29 2022-06-27 PS Planned sale

Trachtenberg Eric

SEE REMARKS

Officer
2,613 -2.3%
0.37
USD 967
2,613 -2.3% 0.37 USD 967
2022-05-26 2022-05-26 S Sale

RA CAPITAL MANAGEMENT, L.P.

Large shareholder
1,005,686 -12.5%
0.36
USD 365,667
1,005,686 -12.5% 0.36 USD 365,667
2022-05-25 2022-05-25 S Sale

RA CAPITAL MANAGEMENT, L.P.

Large shareholder
1,434,509 -15.1%
0.42
USD 602,494
1,434,509 -15.1% 0.42 USD 602,494
2022-05-25 2022-05-24 S Sale

RA CAPITAL MANAGEMENT, L.P.

Large shareholder
144,805 -1.5%
0.51
USD 73,851
144,805 -1.5% 0.51 USD 73,851
2022-05-25 2022-05-23 S Sale

RA CAPITAL MANAGEMENT, L.P.

Large shareholder
1,250,000 -11.5%
0.65
USD 812,500
1,250,000 -11.5% 0.65 USD 812,500
2022-01-05 2022-01-04 PS Planned sale

Trachtenberg Eric

SEE REMARKS

Officer
2,850 -2.4%
1.30
USD 3,705
2,850 -2.4% 1.30 USD 3,705
2022-01-05 2022-01-04 PS Planned sale

Bazemore Todd

SEE REMARKS

Officer
3,454 -2.8%
1.30
USD 4,490
3,454 -2.8% 1.30 USD 4,490
2022-01-05 2022-01-04 PS Planned sale

Brazzell Romulus K

SEE REMARKS

Officer
3,504 -1.2%
1.30
USD 4,555
3,504 -1.2% 1.30 USD 4,555
2022-01-05 2022-01-04 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
9,518 -3.5%
1.30
USD 12,373
9,518 -3.5% 1.30 USD 12,373
2022-01-05 2022-01-04 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
2,850 -2.1%
1.30
USD 3,705
2,850 -2.1% 1.30 USD 3,705
2021-10-28 2021-10-27 PS Planned sale

Chen Hongming

CHIEF SCIENTIFIC OFFICER

Officer
21,051 -9.3%
1.82
USD 38,313
21,051 -9.3% 1.82 USD 38,313
2021-10-28 2021-10-26 PS Planned sale

Iwicki Mark T

CHIEF EXECUTIVE OFFICER

Executive Director
27,598 -9.3%
1.80
USD 49,676
27,598 -9.3% 1.80 USD 49,676
2021-10-28 2021-10-26 PS Planned sale

Chen Hongming

CHIEF SCIENTIFIC OFFICER

Officer
9,449 -4.0%
1.80
USD 17,008
9,449 -4.0% 1.80 USD 17,008
2021-10-28 2021-10-26 PS Planned sale

Trachtenberg Eric

SEE REMARKS

Officer
9,449 -7.5%
1.80
USD 17,008
9,449 -7.5% 1.80 USD 17,008
2021-10-28 2021-10-26 PS Planned sale

Brazzell Romulus K

CHIEF MEDICAL OFFICER

Officer
12,757 -4.2%
1.80
USD 22,963
12,757 -4.2% 1.80 USD 22,963
2021-10-28 2021-10-26 PS Planned sale

Bazemore Todd

CHIEF OPERATING OFFICER

Officer
12,544 -9.3%
1.80
USD 22,579
12,544 -9.3% 1.80 USD 22,579
2021-10-28 2021-10-26 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
9,449 -6.5%
1.80
USD 17,008
9,449 -6.5% 1.80 USD 17,008
2021-06-29 2021-06-28 PS Planned sale

Chen Hongming

CHIEF SCIENTIFIC OFFICER

Officer
2,452 -1.0%
5.77
USD 14,148
2,452 -1.0% 5.77 USD 14,148
2021-06-29 2021-06-28 PS Planned sale

Brazzell Romulus K

CHIEF MEDICAL OFFICER

Officer
3,034 -1.0%
5.77
USD 17,506
3,034 -1.0% 5.77 USD 17,506
2021-06-29 2021-06-28 PS Planned sale

Reumuth Mary

CHIEF FINANCIAL OFFICER

Officer
2,452 -1.7%
5.77
USD 14,148
2,452 -1.7% 5.77 USD 14,148
2021-06-29 2021-06-28 PS Planned sale

Trachtenberg Eric

SEE REMARKS

Officer
2,452 -1.9%
5.77
USD 14,148
2,452 -1.9% 5.77 USD 14,148
2020-10-28 2020-10-22 B Purchase

Bazemore Todd

Chief Operating Officer

Officer
40 +2000.0%
7.60
USD 304
40 +2000.0% 7.60 USD 304
2020-10-28 2020-06-05 B Purchase

Bazemore Todd

Chief Operating Officer

Officer
2 +inf%
13.39
USD 27
2 +inf% 13.39 USD 27
2020-03-17 2020-03-16 B Purchase

Bazemore Todd

Chief Operating Officer

Officer
10,000 +inf%
5.75
USD 57,500
10,000 +inf% 5.75 USD 57,500
2020-03-16 2020-03-13 B Purchase

Grunberg Gregory

Non-Executive Director
2,534,854 +inf%
7.89
USD 19,999,998
2,534,854 +inf% 7.89 USD 19,999,998
2020-03-13 2020-03-13 B Purchase

RA CAPITAL MANAGEMENT, L.P.

Non-Executive Director Large shareholder
6,337,135 +139.7%
7.89
USD 49,999,995
6,337,135 +139.7% 7.89 USD 49,999,995
2020-03-13 2020-03-13 B Purchase

Shah Rajeev M.

Non-Executive Director Large shareholder
6,337,135 +139.7%
7.89
USD 49,999,995
6,337,135 +139.7% 7.89 USD 49,999,995
2019-06-03 2019-05-30 B Purchase

Rosen Howard B

5,000 +154.3%
5.42
USD 27,100
5,000 +154.3% 5.42 USD 27,100
2018-10-09 2018-10-05 B Purchase

Grunberg Gregory

Non-Executive Director
606,060 +26.7%
8.25
USD 4,999,995
606,060 +26.7% 8.25 USD 4,999,995
2018-10-05 2018-10-03 B Purchase

Shah Rajeev M.

Non-Executive Director Large shareholder
2,424,242 +114.7%
8.25
USD 19,999,997
2,424,242 +114.7% 8.25 USD 19,999,997
2018-10-05 2018-10-03 B Purchase

RA CAPITAL MANAGEMENT, LLC

Non-Executive Director Large shareholder
2,424,242 +114.7%
8.25
USD 19,999,997
2,424,242 +114.7% 8.25 USD 19,999,997
2018-02-12 2018-02-08 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
25,000 +0.7%
12.93
USD 323,250
25,000 +0.7% 12.93 USD 323,250
2018-02-06 2018-02-02 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
37,840 +1.1%
14.73
USD 557,383
37,840 +1.1% 14.73 USD 557,383
2018-02-02 2018-02-01 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
22,840 +0.7%
14.99
USD 342,372
22,840 +0.7% 14.99 USD 342,372
2018-02-02 2018-01-31 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
339,400 +11.2%
15.00
USD 5,091,000
339,400 +11.2% 15.00 USD 5,091,000
2018-01-30 2018-01-29 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
50,000 +1.7%
14.99
USD 749,500
50,000 +1.7% 14.99 USD 749,500
2018-01-30 2018-01-26 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
22,760 +0.8%
14.93
USD 339,807
22,760 +0.8% 14.93 USD 339,807
2018-01-24 2018-01-24 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
64,637 +2.2%
14.91
USD 963,738
64,637 +2.2% 14.91 USD 963,738
2018-01-24 2018-01-23 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
4,363 +0.2%
14.99
USD 65,401
4,363 +0.2% 14.99 USD 65,401
2018-01-24 2018-01-22 B Purchase

ORBIMED ADVISORS LLC

Large shareholder
75,000 +2.7%
14.98
USD 1,123,500
75,000 +2.7% 14.98 USD 1,123,500
// ... existing code ... // ... rest of the file ...